Brainomix 360 e-CTA vs RadioLens

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Brainomix 360 e-CTA

by Brainomix Limited

RadioLens

by Synapsica

AI Verdict

Brainomix 360 e-CTA is a specialized AI module focused on acute stroke detection and assessment using CT angiography. RadioLens, on the other hand, is a broader AI-powered RIS/PACS solution designed to automate and enhance general radiology workflows and reporting. While both utilize AI in radiology, Brainomix 360 e-CTA is a niche tool for stroke specialists, whereas RadioLens offers a comprehensive platform for overall radiology department efficiency.

Choose Brainomix 360 e-CTA if…

Choose Brainomix 360 e-CTA if your primary need is rapid, AI-powered analysis of CT angiography scans specifically for acute stroke patients. This tool excels at automating collateral assessment, detecting large vessel occlusions (LVOs), and providing critical insights to guide urgent treatment decisions like thrombectomy. It is designed to integrate seamlessly into the stroke pathway, offering features like email notifications and DICOM results sent to PACS to streamline communication and workflow in time-sensitive stroke care.

View Brainomix 360 e-CTA →

Choose RadioLens if…

Choose RadioLens by Synapsica if you require a comprehensive AI-powered RIS/PACS solution to automate and optimize your entire radiology workflow, beyond just stroke imaging. This tool offers features like intelligent reporting templates, automated case assignments, and a customizable worklist with risk-based prioritization, making it ideal for improving overall diagnostic accuracy, reporting speed, and workload management across various modalities. Its lightweight DICOM viewer also allows for mobile access, enhancing flexibility for radiologists.

View RadioLens →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Brainomix 360 e-CTA	RadioLens
Pricing	Contact vendor	Contact for pricing
Deployment	Cloud service (EU and US) and on-site server within the hospital network.	Cloud Hosted; On-Premise; Hybrid
FDA Status	1 AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

RadioLens

RadioLens emphasizes an easy-to-use dashboard and user interface, with a lightweight DICOM viewer accessible on mobile devices, enhancing flexibility for radiologists. Brainomix 360 e-CTA also offers a mobile app and web UI for viewing results, but RadioLens's focus on streamlining the entire PACS/RIS workflow suggests a broader approach to usability within the daily tasks of a radiologist.

Clinical Value

Brainomix 360 e-CTA

Brainomix 360 e-CTA is specifically designed for acute stroke patients, providing automated collateral assessment, LVO detection, and CTA acquisition phase indication. Multiple peer-reviewed studies validate Brainomix 360's performance in real-world settings, demonstrating high accuracy for LVO detection and significant impact on patient outcomes, including increased thrombectomy rates and improved functional independence. While RadioLens offers AI-enabled insights for diagnostic accuracy and reporting, its clinical validation information is not as extensively detailed or readily available as Brainomix 360 e-CTA's.

Pricing & Value

Tie

Both Brainomix 360 e-CTA and RadioLens use a 'contact vendor' pricing model, making direct comparison of costs difficult. Brainomix offers individual modules or packages, while RadioLens provides yearly, monthly, or one-time perpetual license options. Without transparent pricing, it's challenging to determine which offers better value.

Enterprise Readiness

RadioLens

RadioLens is an AI-powered RIS/PACS solution, indicating a comprehensive approach to managing radiology workflows, including automated assignments for workload optimization and customizable worklists. It also offers cloud-hosted, on-premise, and hybrid deployment options, providing flexibility for various enterprise IT infrastructures. Brainomix 360 e-CTA, while offering cloud and on-site deployment and integration with PACS, is a module within a stroke platform, suggesting a more specialized rather than broad enterprise solution.

Innovation

Brainomix 360 e-CTA

Brainomix 360 e-CTA focuses on highly specialized AI for acute stroke imaging, including automated collateral assessment and CTA collateral scoring, which are critical for time-sensitive stroke interventions. Its integration within the broader Brainomix 360 Stroke platform, which covers NCCT, CTP, and MRI, demonstrates a deep and innovative approach to stroke care. While RadioLens offers innovative AI for workflow automation and reporting, Brainomix's specialized focus on stroke diagnostics represents a more targeted and potentially impactful innovation in a critical clinical area.

Support & Docs

Tie

Both companies state they offer support. Brainomix provides FAQs, user manuals, and contact information. RadioLens offers email/help desk, FAQ/forum, phone support, and chat, along with live online sessions, documentation, and videos for training. Without specific user reviews or detailed service level agreements for either, it is difficult to definitively declare a winner in terms of the quality or responsiveness of their support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Brainomix 360 e-CTA	RadioLens
Name	Brainomix 360 e-CTA	RadioLens
Company	Brainomix Limited	Synapsica
Description	AI-powered module within the Brainomix 360 Stroke platform that automates and standardizes the assessment of collaterals and detects large vessel occlusions on CT angiography scans for acute stroke patients.	AI-powered RIS/PACS solution that automates radiology workflows, enhances diagnostic accuracy, and accelerates reporting through AI-enabled insights and intelligent tools.
Categories	Clinical Decision Support & Reference, Neurology AI, Radiology & Imaging AI	Clinical Decision Support & Reference, Documentation & Scribing, Radiology & Imaging AI
Specialties	Emergency Medicine, Neurology, Radiology	Radiology
Key Features (Partial)	Automated collateral assessment on CTA scans, Computation of CTA Collateral Score (CTA-CS), Automatic Large Vessel Occlusion (LVO) detection	AI-enabled RIS/PACS solution, Fast image uploads and downloads, Lightweight DICOM Viewer accessible on mobile devices

Videos

Demos, reviews, and walkthroughs featuring Brainomix 360 e-CTA and RadioLens.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing radiology workflows and EHR systems?

Brainomix 360 e-CTA integrates within the broader Brainomix 360 Stroke platform, automatically sending DICOM results to PACS or other radiology systems and providing email notifications. RadioLens, on the other hand, is an AI-powered RIS/PACS solution designed to automate radiology workflows, offering integration with AI reporting assistants and supporting HL7 for EHR connectivity.

What is the accuracy and sensitivity of each tool for its stated purpose?

Brainomix 360 e-CTA has shown a sensitivity of 0.86 and specificity of 0.88 for detecting intracranial large vessel occlusions (LVOs) in real-world settings, though its positive predictive value was lower at 0.35, meaning over half of reported occlusions were false positives. RadioLens aims to enhance diagnostic accuracy and reporting speed through AI-enabled quantitative and qualitative insights, and automated pathology detection for certain modalities like MRI Spine and Chest X-rays.

For which specific clinical specialties are these tools best suited?

Brainomix 360 e-CTA is specifically designed for acute stroke patients, focusing on emergency medicine, neurology, and radiology to assess collaterals and detect large vessel occlusions on CT angiography scans. RadioLens is a broader AI-enabled RIS/PACS solution primarily suited for radiology, aiming to automate workflows and enhance reporting across various modalities.

What is the typical learning curve for physicians adopting these AI tools?

While specific learning curve details aren't provided, Brainomix 360 e-CTA is a decision support tool intended to be used as an adjunct to expert interpretation, suggesting that radiologists should still be competent in CTA interpretation. RadioLens emphasizes an intuitive workflow design and user-friendly installation, which may suggest a less steep learning curve for its general radiology workflow automation features.

What kind of audit trail features do these tools offer to ensure data integrity and accountability?

Brainomix 360 e-CTA, as a medical device software, would be expected to maintain an audit trail for regulatory compliance, though specific features are not detailed. RadioLens, as a PACS solution, would also be expected to have audit trail capabilities, which are crucial for tracking actions on imaging data and ensuring data integrity in clinical imaging.

How do these tools support multi-site rollouts and network-wide implementation?

Brainomix 360 e-CTA is part of the Brainomix 360 Stroke platform, which offers a 'virtual hub' for secure real-time sharing of images and patient characteristics across unconnected networks, and a mobile app for quick access to AI-powered scan results across a stroke network. RadioLens is described as suitable for remote reporting requirements of multi-center organizations and can be scaled for all radiology environments, from small diagnostic centers to large multi-geography healthcare networks.

What clinical evidence supports the time-to-value and improved patient outcomes for these tools?

Brainomix 360 Stroke, which includes e-CTA, has been associated with a 100% increase in endovascular thrombectomy rates and a 64-minute reduction in door-in-door-out times, leading to more patients achieving functional independence. RadioLens aims to improve turnaround time by 80% and enhance diagnostic accuracy, contributing to faster reporting and better collaboration, though specific clinical outcome studies are not provided.